NEW YORK (GenomeWeb News) – Cellumen said today that it has entered into a research collaboration with the National Center for Toxicological Research, part of the US Food and Drug Administration, to test known liver toxicity drugs.
 
Cellumen will use its CellCiphr cell-based assay to create profiles of blinded samples of these compounds from failed and marketed drugs, and the NCTR will incorporate information about these drugs into a liver toxicity knowledge database.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The UK's Human Fertility and Embryology Authority calls for consumer genetic testing companies to warn customers that testing could uncover family secrets, according to the Guardian.

The New York Times reports that United Nations delegates have been discussing how to govern the genetic resources of the deep sea.

Researchers have transplanted edited cells into mice that appear to combat cocaine addiction, New Scientist reports.

In PNAS this week: analysis of proteolytic enzymes secreted by circulating tumor cells, phylogenetic study of Fv1 evolution, and more.